BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10213574)

  • 21. Disease-of-the-month alive and well.
    Culliton BJ
    Nature; 1992 Nov; 360(6399):13. PubMed ID: 1436066
    [No Abstract]   [Full Text] [Related]  

  • 22. National Cancer Act: a look back and forward.
    Vanchieri C
    J Natl Cancer Inst; 2007 Mar; 99(5):342-5. PubMed ID: 17341721
    [No Abstract]   [Full Text] [Related]  

  • 23. Opponents of US earmarks propose reviews to temper worst elements of growing practice.
    Anderson C
    Nature; 1992 Nov; 360(6399):4-5. PubMed ID: 1436072
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.
    Griggs JJ; Culakova E; Sorbero ME; van Ryn M; Poniewierski MS; Wolff DA; Crawford J; Dale DC; Lyman GH
    J Clin Oncol; 2007 Jan; 25(3):277-84. PubMed ID: 17159190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Department of Defense leading breast cancer research into the future.
    Rich IM
    AWHONN Voice; 1995; 3(9):1, 8. PubMed ID: 8535359
    [No Abstract]   [Full Text] [Related]  

  • 26. Stamp out cancer.
    Ratzan SC
    J Health Commun; 1999; 4(3):167-8. PubMed ID: 10977286
    [No Abstract]   [Full Text] [Related]  

  • 27. Riding the road to a cure.
    Ferrar A
    InTouch; 2002 May; 4(3):39-42. PubMed ID: 12398046
    [No Abstract]   [Full Text] [Related]  

  • 28. Science careers: a hard sell in tough times.
    Printz C
    Cancer; 2009 Apr; 115(8):1589-90. PubMed ID: 19350538
    [No Abstract]   [Full Text] [Related]  

  • 29. New insurance option to cover breast and cervical cancer.
    Health Care Financ Rev; 2000; 21(3):282. PubMed ID: 11481760
    [No Abstract]   [Full Text] [Related]  

  • 30. Who will pay for our future?
    Richards MJ
    Wis Med J; 1995 Oct; 94(10):529-30. PubMed ID: 8560905
    [No Abstract]   [Full Text] [Related]  

  • 31. A review of breast conservation in Columbia/HCA healthcare facilities.
    Stanfill PH; Weber D
    J Oncol Manag; 1998; 7(5):19-23. PubMed ID: 10187173
    [No Abstract]   [Full Text] [Related]  

  • 32. Coverage for cancer treatment extended to poor women in US.
    Josefson D
    BMJ; 2000 May; 320(7246):1360. PubMed ID: 10818017
    [No Abstract]   [Full Text] [Related]  

  • 33. Health insurance: coverage of autologous bone marrow transplantation for breast cancer.
    Jaggar SF
    Oncology (Williston Park); 1996 Sep; 10(9):1329-32, 1337-8, 1340 passim. PubMed ID: 8882925
    [No Abstract]   [Full Text] [Related]  

  • 34. Vital breast cancer drugs highlight funding ethics.
    Bateman C
    S Afr Med J; 2008 Nov; 98(11):833-4, 836. PubMed ID: 19177884
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women.
    Subramanian S; Trogdon J; Ekwueme DU; Gardner JG; Whitmire JT; Rao C
    Med Care; 2011 Jan; 49(1):89-95. PubMed ID: 21079524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer grant policy comes under fire.
    Wadman M
    Nature; 1996 Sep; 383(6596):113. PubMed ID: 8774873
    [No Abstract]   [Full Text] [Related]  

  • 37. The Breast Cancer Research Foundation; a cure in our lifetime.
    Neoplasia; 2002; 4(3):275-7. PubMed ID: 11988848
    [No Abstract]   [Full Text] [Related]  

  • 38. Financial facts about treating breast cancer.
    Smith MD; McGhan WF
    Bus Health; 1996 Dec; 14(12):67-8, 70. PubMed ID: 10163993
    [No Abstract]   [Full Text] [Related]  

  • 39. NIH and Army meet on breast cancer windfall.
    Watson T
    Nature; 1992 Oct; 359(6398):764. PubMed ID: 1436043
    [No Abstract]   [Full Text] [Related]  

  • 40. Lobbyists prompt US breast cancer campaign.
    Gershon D
    Nature; 1993 Dec; 366(6456):601. PubMed ID: 8259198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.